Definitive Contract H9240520C0004
Award Date 12/11/19
Potential Completion Date 5/10/22
Potential Value $1.4M
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed Set-Aside Type
Total Small Business
Federal Contract Vehicle
- Not listed
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed Similar Awards
- Rejuvenate Bio Inc., a for-profit small business, was awarded a $2,220,133.00 cost-plus-fixed-fee contract by the United States Special Operations Command (USSOCOM) to conduct Small Business Technology Transfer (STTR) Phase II research and prototype development related to neuroenhancement and human performance optimization technologies. The award, which was designated as a total small business set-aside, supports Rejuvenate Bio's ongoing research initiatives aimed at enhancing the capabilities...
- This federal contract was awarded by the United States Special Operations Command (USSOCOM) to Rejuvenate Bio Inc., a for-profit small business, for SBIR Phase II research and prototype development related to neuroenhancement and human performance optimization technologies. The $1,975,972.00 cost-plus-fixed-fee contract was designated as a total small business set-aside. Rejuvenate Bio Inc. has previously received other SBIR Phase I, II, and II plus prototype development awards from USSOCOM,...
- This is a $2,146,157.51 Small Business Innovation Research (SBIR) Phase II contract awarded by the United States Special Operations Command (USSOCOM) to Rejuvenate Bio Inc., a for-profit small business. The contract is for research and prototype development services related to neuroenhancement and human performance optimization technologies intended to enhance the capabilities of special operations forces. The contract is a cost-plus-fixed-fee definitive contract with a performance period from...
- This contract was awarded by the United States Special Operations Command (USSOCOM) to Rejuvenate Bio Inc., a for-profit small business, to conduct a feasibility study under the Small Business Innovation Research (SBIR) Phase I program. The contract, valued at $149,991.00, is for research related to the topic of "Improving Human Performance Through Neuroenhancement" and has a completion date of May 9, 2019. The contract was designated as a total small business set-aside and is a...
- This federal contract award, identified as H9240522C0005, was issued by the United States Special Operations Command (USSOCOM) to Rejuvenate Bio Inc., a small business, for the SBIR Phase II topic 182-002 "Neuroenhancement". The cost-plus-fixed-fee contract has a ceiling value of $2,992,731.00 and a final completion date of December 16, 2024. The contract was set aside for small businesses and involves research and prototype development services related to neuroenhancement and human...
- This is a Small Business Innovation Research (SBIR) Program Phase I contract awarded by the Joint Program Executive Office for Chemical and Biological Defense, a Department of Defense agency, to Bioo Scientific Corporation, a subsidiary of Revvity Inc. The $116,638.65 firm-fixed-price contract supports research and development work related to the SBIR program. The contract was awarded on June 14, 2016, with a completion date of June 13, 2017. As an SBIR Phase I contract, this award supports...
- This is a firm fixed-price purchase order contract awarded by the United States Special Operations Command (USSOCOM) to Apollo Neuroscience, Inc., a self-certified small disadvantaged, woman-owned small business. The $149,823.60 contract is for a Phase I Small Business Innovation Research (SBIR) feasibility study under Topic SOCOM182-002, "Improving Human Performance through Neuroenhancement". The study is to be performed in Pittsburgh, PA and was awarded on November 7, 2018 with a...
- This is a $8,340,352.00 Other Transaction Agreement awarded by the U.S. Special Operations Command (USSOCOM) to Liberty Biosecurity LLC, a self-certified small disadvantaged business. The contract is for pre-clinical and Phase IIA human performance trial work, with a period of performance ending on February 28, 2026. The contract does not have a set-aside designation. Based on the agency, the work is likely supporting USSOCOM's research and development efforts related to human performance...
- <p>This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the U.S. Department of the Army Materiel Command Research Development and Engineering Command to Biodesigns, Inc., a for-profit Subchapter S corporation. The $148,505.30 firm fixed-price contract is for research under the SBIR program. The contract has a completion date of October 31, 2020 and was awarded on September 19, 2019. The place of performance is Thousand Oaks, CA.</p>
- This is a $2,266,107.00 fixed-price cost-plus-fixed-fee contract awarded by the United States Special Operations Command (USSOCOM) to Surany Research And Development LLC, a small business contractor. The contract was awarded under the Small Business Innovation Research (SBIR) Phase II program and is focused on research and development related to the coronavirus (COVID-19) pandemic. The contract has a period of performance through March 31, 2022. Surany Research And Development LLC has previously...